The global market is increasing, due to growing female geriatric population and increasing incidence of uterine malformations. In addition, the growing female infertility cases, increasing cases with abnormal uterine bleeding and growing demand for easy to use at home diagnostic devices are encouraging the growth of the global female fertility and pregnancy rapid test market.
The increasing aging population is propelling the growth of the global female fertility and pregnancy rapid test market, as the elderly population is more susceptible to gynaecological problems, such as abnormal uterine bleeding, fibroids, and polyps, as compared to adults, which is fuelling the demand female fertility and pregnancy rapid tests. Aging leads to changes in hormones leading to irregular menses, which contribute to the demand for hormonal tests, thus driving the growth of the market.
Request to free sample report: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market/report-sample
The advantageous features possessed by these at home pregnancy and fertility rapid test attract the patients around the world to opt for such easy to use devices instead of going for a lab based test. At home fertility and pregnancy rapid test are time saving, comparatively economical, helps maintain privacy and can be used by the females at the comfort of their home; thus, generating a high demand for at home diagnostic devices fuelling the growth of the global female fertility and pregnancy rapid test market
However, the availability of alternative diagnostic test such as blood test and reagent based laboratory test are inhibiting the growth of the global female fertility and pregnancy rapid test market. In addition, the high cost of midstreams, in comparison to strips/dipsticks and cassettes/cards make them less affordable by the patient pool is further restraining the growth of the market. The Asian market is expected to witness the fastest growth during the period 2016 – 2022.
The key companies operating in the global female fertility and pregnancy rapid test market include Alere Inc., Atlas Medical, Diagnostic Automation/Cortez Diagnostics Inc., BioMerieux SA, SA Scientific, Church & Dwight Co., Inc.., Nantong Egens Biotechnology Co. Ltd., and Gemc Technology Group Co., Ltd.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]